COOK CELECT AND GUNTHER TULIP VENA CAVA FILTER SETS
Device Facts
| Record ID | K121057 |
|---|---|
| Device Name | COOK CELECT AND GUNTHER TULIP VENA CAVA FILTER SETS |
| Applicant | William Cook Europe Aps |
| Product Code | DTK · Cardiovascular |
| Decision Date | May 4, 2012 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 870.3375 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The Günther Tulip Vena Cava Filter implant is intended for the prevention of recurrent pulmonary embolism (PE) via placement in the vena cava in the following situations: - Pulmonary thromboembolism when anticoagulant therapy is contraindicated; . - Failure of anticoagulant therapy in thromboembolic diseases; . - Emergency treatment following massive PE where anticipated benefits of . conventional therapy are reduced; and - Chronic, recurrent PE where anticoagulant therapy has failed or is . contraindicated. The Gunther Tulip Vena Cava Filter implant may be retrieved. Please refer to the Instructions for Use provided with the Günther Tulip Vena Cava Filter Retrieval Set (not included in the filter set). The product is intended for percutaneous placement via a femoral vein for filtration of inferior vena cava (IVC) blood to prevent PE. The Cook Celect Filter implant is intended for the prevention of recurrent pulmonary embolism (PE) via placement in the vena cava in the following situations: - Pulmonary thromboembolism when anticoagulant therapy is contraindicated; . - Failure of anticoagulant therapy in thromboembolic diseases; . - Emergency treatment following massive PE where anticipated benefits of . conventional therapy are reduced; and - Chronic, recurrent PE where anticoagulant therapy has failed or is contraindicated. . The Cook Celect Filter implant may be retrieved. Please refer to the Instructions for Use provided with the Günther Tulip Vena Cava Filter Retrieval Set (not included in the filter set). The product is intended for percutaneous placement via a femoral vein for filtration of inferior vena cava (IVC) blood to prevent pulmonary embolism.
Device Story
Intravascular filters (Günther Tulip and Cook Celect) designed for percutaneous placement in the inferior vena cava (IVC) to prevent recurrent pulmonary embolism. Filters are preloaded in a coaxial introducer sheath system (7.0 French) with a Check-Flo valve and hydrophilically coated predilator (7.5 French). Operated by physicians in clinical settings via femoral or jugular approach. Modification involves a flexible tip on the femoral introducer to improve trackability through venous anatomy. Filters are constructed from conichrome. Clinical benefit derived from mechanical filtration of IVC blood to capture emboli. Device is retrieved using a separate retrieval set.
Clinical Evidence
Bench testing only. Performance data included deployment testing, trackability testing, tensile testing, and biocompatibility testing to verify design reliability and performance of the modified femoral introducer tip.
Technological Characteristics
Conichrome filter material; 7.0 French coaxial introducer sheath with Check-Flo valve; 7.5 French injectable dilator with 8 sideports; hydrophilically coated predilator. Modified femoral introducer tip for trackability. Mechanical device; no software or energy source.
Indications for Use
Indicated for patients with pulmonary thromboembolism where anticoagulation is contraindicated, failed, or in emergency cases of massive PE where conventional therapy benefits are reduced. Applicable for chronic, recurrent PE. Intended for percutaneous placement in the IVC via femoral or jugular vein.
Regulatory Classification
Identification
A cardiovascular intravascular filter is an implant that is placed in the inferior vena cava for the purpose of preventing pulmonary thromboemboli (blood clots generated in the lower limbs and broken loose into the blood stream) from flowing into the right side of the heart and the pulmonary circulation.
Special Controls
*Classification.* Class II. The special controls for this device are:(1) “Use of International Standards Organization's ISO 10993 ‘Biological Evaluation of Medical Devices Part I: Evaluation and Testing,’ ” and (2) FDA's: (i) “510(k) Sterility Review Guidance and Revision of 2/12/90 (K90-1)” and (ii) “Guidance for Cardiovascular Intravascular Filter 510(k) Submissions.”